Grace Friel

发表

The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, E. Goode, 2016, International Journal of Gynecologic Cancer.

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, A. Whittemore, 2013, Human Genetics.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.

Aspirin and Acetaminophen Use and the Risk of Cervical Cancer

K. Odunsi, K. Moysich, S. Lele, 2015, Journal of lower genital tract disease.

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Yurii B. Shvetsov, Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, 2016, Oncotarget.

Use of Common Analgesics Is Not Associated with Ovarian Cancer Survival

J. Freudenheim, R. Ness, K. Odunsi, 2015, Cancer Epidemiology, Biomarkers and Prevention.

History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report

J. Chang-Claude, A. deFazio, B. Karlan, 2017, British Journal of Cancer.

History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium

L. Kiemeney, J. Chang-Claude, B. Karlan, 2017, Cancer Causes & Control.

History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium

L. Kiemeney, J. Chang-Claude, B. Karlan, 2017, Cancer Causes & Control.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Dong Liang, Jane E. Carpenter, Peter Kraft, 2016 .

Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study

K. Moysich, G. Zirpoli, R. Cannioto, 2015, International Journal of Gynecologic Cancer.

Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, M. Pike, 2016, British Journal of Cancer.

History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

L. Kiemeney, M. Beckmann, P. Fasching, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Impact of Physical Inactivity on Risk of Developing Cancer of the Uterine Cervix: A Case-Control Study

K. Odunsi, K. Moysich, S. Lele, 2016, Journal of lower genital tract disease.

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

David N. Rider, A. Whittemore, L. Kiemeney, 2014, Cancer research.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Jane E. Carpenter, Lara E Sucheston-Campbell, Ali Amin Al Olama, 2016 .

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Jane E. Carpenter, Lara E Sucheston-Campbell, A. Whittemore, 2016, Journal of Medical Genetics.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.

Use of Common Analgesics Is Not Associated with Ovarian Cancer Survival

J. Freudenheim, R. Ness, K. Odunsi, 2015, Cancer Epidemiology, Biomarkers & Prevention.